Herpes simplex virus type 1 (HSV-1) can induce a robust immune response initially thru the activation of pattern recognition receptors and subsequent type I interferon production that then shapes, along with other innate immune components, the adaptive immune response to the insult. While this response is necessary to quell virus replication, drive the pathogen into a "latent" state, and likely hinder viral reactivation, collateral damage can ensue with demonstrable cell death and foci of tissue pathology in the central nervous system (CNS) as a result of the release of inflammatory mediators including reactive oxygen species. Although rare, HSV-1 is the leading cause of frank sporadic encephalitis that, if left untreated, can result in death. A greater understanding of the contribution of resident glial cells and infiltrating leukocytes within the CNS in response to HSV-1 invasion is necessary to identify candidate molecules as targets for therapeutic intervention to reduce unwarranted inflammation coinciding with the maintenance of the anti-viral state.
1.
Introduction to herpes simplex virus- 
Introduction to herpes simplex virus-1
HSV-1 is a double-stranded DNA virus with a genome size of 152 kb encoding for at least 84 different polypeptides (McGeoch et al., 1988) . During an in vitro acute infection, the lytic nature of the virus is driven by a sequential cascade of genes (referred to as lytic genes) expressed collectively over the course of the first 8-12 h following entry into the host cell and includes the immediate early or α genes, early or β genes, and late or γ genes (Honess and Roizman, 1974) . It is now appreciated that many of these genes encode proteins that serve dual functions: assist in the replication of virus and counter the innate or adaptive immune response to the pathogen. Ultimately, the success rate of the virus within the human host is dependent upon its ability to establish a latent infection and then reactivate at opportune times and shed into bodily secretions that are passed vertically or horizontally to a naive patient.
Herpes spread into the CNS
HSV-1 gains entry into cells by binding to heparan sulfate proteoglycan and invading the host cell (neurons) during primary infection (Shieh et al., 1992; WuDunn and Spear, 1989) . It has been Journal of Neuroimmunology 220 (2010) 1-9
